Ampersand Planning Expanded InPath Cervical Cell Analysis System Trials
This article was originally published in The Gray Sheet
Executive Summary
Expanded trials of Ampersand Medical's InPath cervical cell collection and analysis system for cancer screening are expected to begin in the next few months at five centers worldwide, following the announcement of "promising" initial findings on Jan. 18.